SB
IBB icon

Suntrust Banks’s iShares Biotechnology ETF IBB Stock Holding History

Suntrust Banks’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.65M Sell
36,637
-5,540
-13% -$580K 0.02% 418
2019
Q2 		$4.6M Sell
42,177
-5,332
-11% -$567K 0.02% 367
2019
Q1 		$5.31M Buy
47,509
+5,131
+12% +$563K 0.03% 324
2018
Q4 		$4.09M Sell
42,378
-20,604
-33% -$2.19M 0.02% 352
2018
Q3 		$7.68M Buy
62,982
+23,176
+58% +$2.73M 0.04% 262
2018
Q2 		$4.37M Sell
39,806
-9,486
-19% -$1.01M 0.02% 348
2018
Q1 		$5.26M Buy
49,292
+17,127
+53% +$1.9M 0.03% 298
2017
Q4 		$3.43M Sell
32,165
-28,501
-47% -$3.05M 0.02% 354
2017
Q3 		$6.75M Buy
60,666
+14,277
+31% +$1.53M 0.04% 254
2017
Q2 		$4.79M Sell
46,389
-2,934
-6% -$289K 0.03% 306
2017
Q1 		$4.82M Buy
49,323
+4,071
+9% +$390K 0.03% 294
2016
Q4 		$4M Buy
45,252
+30,444
+206% +$2.77M 0.02% 337
2016
Q3 		$1.43M Sell
14,808
-1,962
-12% -$187K 0.01% 662
2016
Q2 		$1.44M Buy
16,770
+5,634
+51% +$506K 0.01% 609
2016
Q1 		$967K Buy
11,136
+4,476
+67% +$400K 0.01% 715
2015
Q4 		$750K Buy
6,660
+948
+17% +$103K ﹤0.01% 808
2015
Q3 		$576K Buy
5,712
+603
+12% +$72.3K ﹤0.01% 825
2015
Q2 		$628K Buy
5,109
+684
+15% +$81.9K ﹤0.01% 783
2015
Q1 		$504K Buy
4,425
+183
+4% +$20.2K ﹤0.01% 827
2014
Q4 		$427K Sell
4,242
-3,735
-47% -$363K ﹤0.01% 857
2014
Q3 		$726K Sell
7,977
-6,204
-44% -$544K 0.01% 812
2014
Q2 		$1.21M Sell
14,181
-22,758
-62% -$1.79M 0.01% 615
2014
Q1 		$2.91M Sell
36,939
-450
-1% -$37.5K 0.01% 573
2013
Q4 		$2.83M Buy
37,389
+33,549
+874% +$2.38M 0.01% 577
2013
Q3 		$268K Hold
3,840
– – ﹤0.01% 1530
2013
Q2 		$222K Buy
+3,840
New +$222K ﹤0.01% 1547

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Suntrust Banks's IBB Position: Q3 2019 in Review

Suntrust Banks reduced its iShares Biotechnology ETF (IBB) stake by 13% in Q3 2019, selling an estimated $580K and leaving 36,637 shares worth $3.65M. The position accounts for 0.02% of the portfolio, ranked #418.

Suntrust Banks first reported a position in IBB in Q2 2013 and has held it in 26 quarters since. The position peaked at $7.68M in Q3 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Suntrust Banks held 36,637 shares of iShares Biotechnology ETF worth $3.65M as of Q3 2019.
  • Suntrust Banks sold 5,540 iShares Biotechnology ETF shares in Q3 2019, an estimated $580K.
  • iShares Biotechnology ETF made up 0.02% of Suntrust Banks's portfolio in Q3 2019, its #418 holding.
  • Suntrust Banks first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 26 quarters since.
  • Suntrust Banks's iShares Biotechnology ETF position peaked at $7.68M in Q3 2018.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.